Institutional Fund
Ikarian Capital, LLC
Dallas, TXCIK 17782535 filings on record
Portfolio Value
$699.01M
Q1 2026
Holdings
127
Reported positions
New Buys
17
Opened this quarter
QoQ Change
-9.5%
from $772.56M
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Terns Pharmaceuticals Inc11.0%
- Kodiak Sciences Inc6.9%
- Alumis Inc3.8%
- Vaxcyte Inc3.6%
- Praxis Precision Medicines I3.3%
- Harrow Inc2.7%
- Other68.7%
Portfolio Holdings
127 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Terns Pharmaceuticals Inc | 1.46M | $76.78M | 11.0% | −140.0K | Reduced |
| 2 | Kodiak Sciences Inc | 1.27M | $48.25M | 6.9% | +546.0K | Added |
| 3 | Alumis Inc | 1.21M | $26.73M | 3.8% | +1.21M | New |
| 4 | Vaxcyte Inc | 428.7K | $24.91M | 3.6% | +50.0K | Added |
| 5 | Praxis Precision Medicines I | 71.6K | $23.06M | 3.3% | −15.0K | Reduced |
| 6 | Harrow Inc | 543.0K | $19.15M | 2.7% | +359.7K | Added |
| 7 | Relmada Therapeutics Inc | 2.69M | $18.71M | 2.7% | −380.0K | Reduced |
| 8 | Cytokinetics Inc | 283.6K | $18.69M | 2.7% | +110.9K | Added |
| 9 | Tenax Therapeutics Inc | 1.02M | $16.27M | 2.3% | +50.0K | Added |
| 10 | Capricor Therapeutics Inc | 528.0K | $16.05M | 2.3% | −50.0K | Reduced |
117 more holdings on Premium
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio